The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
GLP-1 medications extend beyond diabetes and weight loss to enhance overall metabolic health. They improve insulin sensitivity, curb chronic inflammation, and optimize cholesterol levels. Patients often report sustained energy and better wellness.
Three suspects face robbery charges after stealing $16,000 worth of GLP-1 weight loss drugs, including Ozempic, Mounjaro, and Trulicity, from a pharmacy delivery in Bensalem, Pennsylvania. Police quickly apprehended the men from New York following a high-speed chase. The incident highlights surging demand for these popular medications.
Prof Jim Mann cautions against broad funding for Wegovy, urging focus on high-risk patients like those with heart disease or diabetes. He emphasizes integrating GLP-1 medications into a national obesity strategy with mandatory nutritional support to prevent weight regain. Early data highlights side effect risks and the need for dietary counseling.
GLP-1 weight loss drugs like Ozempic and Wegovy are transforming restaurant menus. Major chains now provide smaller servings and protein-rich items as users eat less but prioritize quality. A recent poll shows 12% of Americans on these medications.
Pharmac is evaluating funding for Wegovy, a GLP-1 receptor agonist, to combat New Zealand's high obesity rates. Weight loss specialist Dr. Gerard McQuinlan says it could save taxpayers billions by preventing diseases like Type 2 diabetes. Experts weigh long-term costs, side effects, and criteria.
GLP-1 medications like Ozempic drive rapid weight loss but often trigger 'Ozempic face'—a gaunt, sagging facial look from fat volume loss. Do these drugs truly balance the effects? Evidence shows they don't selectively protect facial areas; targeted strategies are essential.
The Ozempic hype may fade as a BMJ study shows users regain lost weight within 1.5 years after stopping GLP-1 drugs. These medications reduce appetite but require lifelong use and lifestyle changes for lasting results. Obesity stems from systemic issues like convenience culture and ultra-processed foods, not just willpower.
A delivery driver was robbed of $16,000 worth of Ozempic, Mounjaro, and Trulicity outside a Bensalem, PA pharmacy. Three suspects from New York were quickly arrested after assaulting the driver. Rising demand for GLP-1 medications fuels thefts and scams, per KFF survey and BBB alerts.
Emilly dropped from 22st to 9st 2lb on Mounjaro by tackling her plateau with more water and protein. Experts reveal why 85% of GLP-1 users stall and share proven strategies to restart progress. Avoid rapid regain by combining drugs with lifestyle changes.
